SNX19与GRK4竞争调节肾脏多巴胺D1受体磷酸化在高血压病发生中的作用与机制研究
批准号:
82070442
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
杨剑
依托单位:
学科分类:
血压调节异常与高血压病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
杨剑
中文摘要
肾脏多巴胺D1R功能障碍是高血压发生的关键环节,胞膜分布减少是其功能降低的重要原因,但机制尚不清楚。SNX19因与D1R共连接引起关注,前期发现SNX19全身敲除小鼠血压升高,伴肾脏D1R胞膜分布降低;敲低肾近曲小管(RPT)细胞SNX19后,D1R的钠泵抑制作用减弱,表明其可调节D1R功能。既往报道磷酸化影响D1R胞内分布,我们发现敲低SNX19增强D1R磷酸化;高血压下肾脏SNX19表达降低,D1R与其调节激酶GRK4连接增强;恢复其表达逆转D1R磷酸化;分子对接技术预测三者有共结合区域,提示SNX19和GRK4可能竞争结合D1R。推测高血压下肾脏SNX19表达降低,促使GRK4与D1R结合增多,引发其过度磷酸化、D1R胞膜表达与功能降低,导致血压升高。拟利用肾脏特异敲除SNX19小鼠及其RPT细胞研究SNX19与GRK4对D1R磷酸化的竞争调节,阐明高血压下D1R细胞分布异常的原因。
英文摘要
The dysfunction of renal dopamine D1 receptor (D1R) plays a vital role in the development of hypertension. The decreased expression of D1R in the cell membrane is an important cause; however, its mechanism still remains unclear. Sorting nexin 19 (SNX19) drews our attention for its direct connection with D1R. Our previous studies found that in SNX19 global knockout mice, the blood pressure was increased, and the expression of membranal D1R in the kidney is decreased; after knockdown of SNX19 expression in the renal proximal tubule (RPT) cells, D1R-madiated inhibition of Na+ pump was impaired, indicating that SNX19 can regulate the functions of D1R. Intracellular distribution of D1R is modulated by its phosphorylation. Our previous studies found that knockdown of SNX19 expression in the RPT cells increased D1R phosphorylation; in the hypertensive status, the expression of renal SNX19 was decreased, as well as the connection between D1R and G protein-coupled receptor kinase 4 (GRK4) was increased; D1R rescue restored the hyper-phosphorylated D1R. Molecular docking technique predicted that there may be a binding domain among D1R, SNX19 and GRK4, suggesting that SNX19 and GRK4 may competitively bind with D1R. Thus, our hypotheses is that in the hypertensive status, the decreased renal SXN19 expression leads to the increased connection between GRK4 and D1R, inducing D1R hyperphosphorylation, and then impairs its membranal expression and functions, causing the increased blood pressure. Based on the above, we plan to study the competitive regulation of SNX19 and GRK4 on the phosphorylation of renal D1R in the renal SNX19 conditional knockout mice, and illustrate the cause of abnormal membranal and intracellular distribution of D1R in the hypertensive status.
肾脏多巴胺D1R功能障碍是高血压发生的关键环节,SNX19因与其共连接引起关注。本研究在数据库中发现高血压患者肾脏SNX19表达降低。实验证实高血压患者尿沉渣及不同高血压动物模型肾脏SNX19表达减少,明确SNX19主要定位肾脏近曲小管。我们构建了Snx19−/−小鼠,通过鼠尾测压法和植入子遥测法发现Snx19−/−小鼠血压升高,伴随尿钠排泄降低。利用AAV9恢复Snx19−/−小鼠肾脏SNX19表达,发现其对升高的血压及降低的尿钠排泄均有改善。对与尿钠代谢关联的受体筛选后发现部分受体肾脏表达降低。我们选择了最具代表性的D1R和AT2R进一步研究。发现Snx19−/−小鼠肾脏D1R或AT2R介导的尿钠排泄减弱,类似结果在体外实验得到验证。采用超声靶向微泡技术恢复AngII诱导高血压模型肾脏SNX19表达,发现血压升高及尿钠排泄障碍得到好转,并伴随受体表达恢复。进一步发现Snx19−/−小鼠肾脏及Snx19敲低HK-2细胞m6A水平增加;Snx19敲低细胞AT2R和D1R mRNA衰减增加。筛选发现ALKBH5表达降低。我们预测了AT2R和D1R甲基化修饰位点,并在Snx19敲低体外实验中得到证实。并确证了Alkbh5敲低或过表达对AT2R和D1R表达的调节。还观察到ALKBH5和SNX19在动物肾脏共定位及直接连接。发现Snx19敲减没有改变ALKBH5转录水平。Snx19敲低在HK-2细胞中增加了ALKBH5蛋白衰减,且可被溶酶体抑制剂所抑制。Snx19敲减后,ALKBH5的溶酶体定位增加,提示其在溶酶体降解的可能。上述提示降低的SNX19表达,通过增加ALKBH5的溶酶体途径降解,增加促尿钠排泄受体(D1R和AT2R)的mRNA甲基化,降低上述受体表达和促尿钠排泄功能,最终引起血压升高。本研究揭示了利钠性GPCR受损新机制,可能有助于进一步研究降压新策略。
巨噬细胞多巴胺D1受体抑炎效应失调在高血压发生中的作用与机制研究
-
批准号:CSTB2023NSCQ-MSX0313
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:杨剑
-
依托单位:
SNX29介导的巨噬细胞多巴胺D1受体靶向溶酶体转运调节在高血压发生中的作用与机制研究
-
批准号:82370435
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:杨剑
-
依托单位:
TSPO通过VDAC1/NF-κB途径对肾脏AT1受体的调控在高血压发生中的作用研究
-
批准号:81770425
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:杨剑
-
依托单位:
SNX1对肾脏多巴胺D5受体的异常调节在高血压发病机制中的作用研究
-
批准号:81570379
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:杨剑
-
依托单位:
国内基金
海外基金